MENU

LFCR Stock Lifecore Biomedical (LFCR, $4.54) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 9, 2024

A.I.dvisor
at Tickeron.com
10/10/24
Loading...
LFCR - Lifecore Biomedical
MACD signal
Bearish Trend
Odds of DOWN Trend
Tickeron
MACD signal
Price: $4.54
Daily change: -$0.28 (-5.72%)
Daily volume: 163.9K
Industry: Pharmaceuticals: Other
This is a Bearish indicator signaling LFCR's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 45 similar cases where LFCR's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

LFCR in downward trend: price may decline as a result of having broken its higher Bollinger Band on September 19, 2024

LFCR broke above its upper Bollinger Band on September 19, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 39 similar instances where the stock broke above the upper band. In of the 39 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 18, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on LFCR as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LFCR entered a downward trend on October 18, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where LFCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LFCR just turned positive on October 17, 2024. Looking at past instances where LFCR's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

LFCR moved above its 50-day moving average on October 17, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LFCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.789) is normal, around the industry mean (56.825). P/E Ratio (0.000) is within average values for comparable stocks, (89.935). Projected Growth (PEG Ratio) (2.661) is also within normal values, averaging (2.890). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (1.680) is also within normal values, averaging (18.882).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
LFCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of polymer products for food and agricultural products, medical devices and licensed partner applications

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
3515 Lyman Boulevard
Phone
+1 952 368-4300
Employees
459
Web
https://www.lifecore.com